Differential Effects of Eszopiclone Versus Ramelteon in Burned Children

This study is not yet open for participant recruitment.

Verified by Shriners Hospitals for Children, October 2007

First Received: October 2, 2007 Last Updated: October 3, 2007 History of Changes

Sponsor:	Shriners Hospitals for Children
Information provided by:	Shriners Hospitals for Children
ClinicalTrials.gov Identifier:	NCT00539110

Purpose

To examine sleep changes following therapeutic drug interventions designed to promote sleep.

Condition	Intervention
Sleep Burns	Drug: eszopiclone Drug: ramelteon

Study Type:	Interventional
Study Design:	Supportive Care, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Crossover Assignment

Resource links provided by NLM:

MedlinePlus related topics: Burns

Drug Information available for: Eszopiclone Ramelteon

Further study details as provided by Shriners Hospitals for Children:

Primary Outcome Measures:

Secondary Outcome Measures:

Estimated Enrollment:

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00539110

Contacts

Contact: Michele M Gottschlich, PhD, RD, CNSD	513-872-6298	mgottschlich@shrinenet.org
Contact: Theresa Mayes, BS, RD	513-872-6043	tmayes@shrinenet.org

Locations

United States, Ohio
Shriners Hospital for Children
Cincinnati, Ohio, United States, 45229

Sponsors and Collaborators

Shriners Hospitals for Children

Investigators

Principal Investigator:

Michele M Gottschlich

Shriners Hospital for Children

More Information

No publications provided

Study ID Numbers:	Sleep III
Study First Received:	October 2, 2007
Last Updated:	October 3, 2007
ClinicalTrials.gov Identifier:	NCT00539110 History of Changes
Health Authority:	United States: Institutional Review Board

ClinicalTrials.gov processed this record on February 08, 2010